September 30, 2025 — Gilead’s Epclusa (sofosbuvir/velpatasvir, 400mg/100mg) continues to reshape hepatitis C management worldwide. As the first and only all-oral, pan-genotypi...

With the rapid development of precision medicine, targeted drugs have become a key approach in cancer treatment. Unlike traditional chemotherapy, targeted therapy “hits” specific...

When people hear the word “generic drug,” they often think of cheap or low-quality medicine. In fact, this is a big misunderstanding. Generic drugs are not counterfeit medicines;...

When undergoing targeted cancer therapy, diet often becomes a concern for many patients. The truth is, there’s no need for overly strict restrictions, but maintaining a light, bal...

The U.S. Food and Drug Administration (FDA) has officially approved Novartis’ latest gene replacement therapy, Itvisma, marking a significant milestone in the treatment landscape ...

The U.S. Food and Drug Administration has granted approval to Otsuka’s newly developed injectable therapy for patients diagnosed with primary immunoglobulin A nephropathy (IgAN), ...

When discussing overseas generic drugs, “Indian generics” and “Bangladeshi generics” are often mentioned together. Although both are widely used and cost-effective, they differ...

On July 28, 2025 — World Hepatitis Day — Bangladesh-based Beacon Pharmaceuticals officially introduced Sofosvel, the world’s first generic version of Epclusa (SOF/VEL). This mil...

 We’ve all heard the saying, “Your face reflects your mind.” While it often refers to emotions or personality, your face can also reveal clues about your physical health—espec...

Breast cancer remains the most commonly diagnosed cancer among women worldwide. Although its发病 trends and risk factors have been extensively studied, public understanding of how ...